Merck is entering a research collaboration with Isomorphic Labs, the AI drug designer built on a Nobel-winning technology
Results for “reset deal”
Low oxygen levels in the brain, or cerebral anoxia, are a leading cause of death worldwide. Patients who recover from cerebral anoxia deal with persistent neurological issues that worsen their quality of life. Building on previous work showing that brain–heart interactions can predict the severity of symptoms and survival, Diego Candia-Rivera, Sofia Carrion-Falgarona and colleagues from the Paris Brain Institute assessed whether brain–heart interactions in a rat model of severe oxygen loss can predict survival after resuscitation. The work is published in eNeuro.
A deal for smart-ring maker Oura to acquire a telehealth company is raising conflict-of-interest questions for Eli Lilly
With a new deal announced this week, the relationship between Eli Lilly and a telehealth company that markets GLP-1s is expected to grow more complicated.
Pfizer spent up to $10 billion to buy Metsera last year. Now, it’s bringing in private equity behemoth Blackstone to help pay for the deal.
Deaf patients get a raw deal in NHS hospitals, suggests an illustrative case history of a deaf person's experience as an inpatient, published in the online journal BMJ Case Reports. During his hospital stay, reasonable adjustments to facilitate access to services—a key tenet of U.K. disability legislation—weren't made; the need for a professional British Sign Language (BSL) interpreter wasn't recognized soon enough; and frontline staff weren't adequately trained in how to support him.
Health visitors are set to return to work next week, ending a nine-month dispute over pay and grading.
Women are calling for more support to deal with menopause caused by their cancer treatment.
CVS Health’s decision to split comes amid federal and state scrutiny over vertical integration.







